Scynexis (SCYX) Amortizatization of Intangibles (2016 - 2026)
Scynexis' (SCYX) quarterly Amortizatization of Intangibles came in at $41000.0 in Q1 2026, down 79.4% YoY from $199000.0 in Q1 2025, and down 33.87% on a QoQ basis from $62000.0 in Q4 2025.
Scynexis (SCYX) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends
Scynexis (SCYX) has 8 years of Amortizatization of Intangibles data on file, last reported at $41000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 79.4% year-over-year to $41000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $316000.0 (down 75.43% YoY) and the FY2025 annual result came in at $474000.0, down 64.63% from the prior year.
- Amortizatization of Intangibles fell to $41000.0 in Q1 2026, from $62000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $802000.0 in Q3 2023 to a low of -$319000.0 in Q2 2023.
- A 5-year average of $233600.0 and a median of $219000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2023 — Amortizatization of Intangibles surged 791.11% — and 2025, when it sank 79.41%.
- Tracing SCYX's Amortizatization of Intangibles over 5 years: stood at $219000.0 in 2022, then soared by 191.32% to $638000.0 in 2023, then tumbled by 61.91% to $243000.0 in 2024, then slumped by 74.49% to $62000.0 in 2025, then plunged by 33.87% to $41000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $41000.0 (Q1 2026), $62000.0 (Q4 2025), and $98000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Scynexis | 61.90 Mn | -52.80 Mn | - | 95,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 67,000.00 |
| Jun 30, 2026 | 67,000.00 |
| Mar 31, 2026 | 41,000.00 |
| Mar 31, 2026 | 41,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 115,000.00 |
| Mar 31, 2025 | 199,000.00 |
| Mar 31, 2025 | 199,000.00 |
| Dec 31, 2024 | 243,000.00 |
| Dec 31, 2024 | 243,000.00 |
| Sep 30, 2024 | 476,000.00 |
| Sep 30, 2024 | 476,000.00 |
| Jun 30, 2024 | 368,000.00 |
| Jun 30, 2024 | 368,000.00 |
| Mar 31, 2024 | 253,000.00 |
| Mar 31, 2024 | 253,000.00 |